InflaRx N.V. Common Stock (IFRX)
Stock · NASDAQ · Health Care
$1.32as of 10/16/2026
Price chart
Active signals
IFRX Signal Track Record
How signals performed across all stocks →What IFRX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 37 | -2.5% | 49% | October 8, 2026 |
| Bollinger Band Breakout | 23 | -6.4% | 39% | August 18, 2026 |
| 200-Day Moving Average TouchActive now | 18 | +2.3% | 56% | October 6, 2026 |
| Bollinger Band Breakdown | 16 | +9.9% | 75% | September 25, 2026 |
| Any 20-session window (baseline) | -0.9% | 47% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About IFRX
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a a first-in-class monoclonal anti-human complement factor C5a antibody, which is in Phase 3 clinical trial for the trea…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 65
- Website
- www.inflarx.de/
Fundamentals
- 1-day range
- $1.43$1.53
- Market cap
- $124.34M
- P/E (trailing)
- —
- P/E (forward)
- -3.71
- EPS (trailing)
- $-0.35
- Dividend yield
- —
- Beta
- 2.43
- Avg. volume
- 759.6K
Forecasts
9 analyst ratings
InflaRx N.V. Common Stock Competitors
Chosen by industry and closest market cap.
- IFRXInflaRx N.V. Common Stock$1.32▼ 8.33%Market cap $124.34MP/E —$0.7984$2.95
- TLSATiziana Life Sciences Ltd. Common Shares$1.05▲ 0.00%Market cap $123.99MP/E —$0.7615$2.2
- GNLXGenelux Corporation Common Stock$2.42▼ 2.42%Market cap $121.07MP/E —$2.29$8.54
- SPRBSpruce Biosciences Inc. Common Stock$39.65▼ 4.39%Market cap $127.76MP/E —$38.06$179.95
- PMNProMIS Neurosciences Inc. Common Shares (ON)$8.15▼ 6.32%Market cap $119.54MP/E —$6.27$27.4
- BGMBGM Group Ltd. Class A Ordinary Shares$8.65▲ 0.70%Market cap $118.62MP/E —$6.45$303
- YARWYarrow Bioscience Inc. Common Stock$18.31▼ 8.45%Market cap $116.71MP/E —$18.16$44.28
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IFRX InflaRx N.V. Common Stock | $124.34M | — | $1.32 | ▼ 8.33% | $0.7984$2.95 |
| TLSA Tiziana Life Sciences Ltd. Common Shares | $123.99M | — | $1.05 | ▲ 0.00% | $0.7615$2.2 |
| GNLX Genelux Corporation Common Stock | $121.07M | — | $2.42 | ▼ 2.42% | $2.29$8.54 |
| SPRB Spruce Biosciences Inc. Common Stock | $127.76M | — | $39.65 | ▼ 4.39% | $38.06$179.95 |
| PMN ProMIS Neurosciences Inc. Common Shares (ON) | $119.54M | — | $8.15 | ▼ 6.32% | $6.27$27.4 |
| BGM BGM Group Ltd. Class A Ordinary Shares | $118.62M | — | $8.65 | ▲ 0.70% | $6.45$303 |
| YARW Yarrow Bioscience Inc. Common Stock | $116.71M | — | $18.31 | ▼ 8.45% | $18.16$44.28 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga · 10/8/2026
- InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026Yahoo · 10/2/2026
- InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical DevelopmentYahoo · 10/1/2026
- InflaRx to Host Virtual Capital Markets DayYahoo · 9/21/2026
- This GE Vernova Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Mondaybenzinga · 9/14/2026
- This GE Vernova Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For MondayBenzinga · 9/14/2026
- Needham Initiates Coverage On InflaRx with Buy Rating, Announces Price Target of $8Benzinga · 9/14/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
InflaRx to Host Virtual Capital Markets Day
InflaRx announced it will host a virtual Capital Markets Day. This event allows the company to present updates on its business and strategy to investors. The stock is currently trading near its 52-week low, with an RSI of 36.7 indicating recent weakness.
InflaRx to Host Virtual Capital Markets Day. InflaRx announced it will host a virtual Capital Markets Day. This event allows the company to present updates on its business and strategy to investors. The stock is currently trading near its 52-week low, with an RSI of 36.7 indicating recent weakness.